The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 335.00
Bid: 330.00
Ask: 340.00
Change: 3.00 (0.90%)
Spread: 10.00 (3.03%)
Open: 335.00
High: 335.00
Low: 335.00
Prev. Close: 332.00
SOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

5 Jun 2020 07:00

RNS Number : 0063P
Somero Enterprises Inc.
05 June 2020
 

5 June 2020

Somero Enterprises, Inc.

("Somero" or the "Company")

 

COVID-19 Update

Somero® provides the following update on trading and the precautionary actions carried out by the Company in response to the evolving COVID-19 pandemic.

While the Company remains in a strong financial position, because the implications and duration of the COVID-19 pandemic remain difficult to determine, in addition to the previously announced measures, the Company is implementing a range of further precautionary actions to reduce costs and conserve cash during this period of uncertainty.

The Board remains confident in the health of the business and its growth prospects over the long-term and is taking these actions now to ensure the business is in a strong position once the operating environment becomes more normal.

Management actions

As of the date of this update, management has taken the following additional actions, all of which will be kept under constant review as circumstances change:

· Furloughing approximately 20% of our workforce

· Cancelling of all bonus and profit-sharing payments for the calendar year 2020, a decision that impacts all Somero employees not on sales commission plans

· Curtailing discretionary spending across all departments

· Curtailing further capital expenditure beyond what has already been committed to on-going building expansion projects

The annualized pre-tax impact of these cost saving measures is expected to approximate US$ 5.0m.

Financial position and cash management

Somero entered this period of uncertainty with a strong balance sheet and good liquidity and its financial position has been strengthened further by these additional financial and cost saving measures. On 30 March, the Company indicated its net cash position exceeded US$ 24.0m. Management expects its net cash position at the end of 30 June will continue to exceed US$ 24.0m and the Company continues to have access to substantial additional liquidity through its US$ 10.0m line of credit. In addition, the Company will continue to closely monitor, and pursue as applicable, all US government funding opportunities for which the Company may be eligible.

Current trading and outlook

Even though the COVID-19 pandemic has resulted in current trading that has fallen approximately 25% below levels required to achieve the market expectation at the start of the year of US$ 90.0m in 2020 revenues, the Company remains profitable and cash generative. The Board is confident that, following the actions taken by the Company described above, the Company would continue to be cash generative even in the scenario where revenues fall an additional 20% from current levels, to approximately $54.0m, which provides Management substantial flexibility during this challenging period.

Uncertainty around the scale, duration and impact of the COVID-19 pandemic on Somero's end markets in the non-residential construction industry, makes it difficult at this time to provide further guidance on the Company's financial performance in the rest of 2020 and beyond. While extended project backlogs reported by our customers prior to the COVID-19 pandemic, particularly in the US, indicate the non-residential construction market was active and healthy entering this period, financial performance for 2020 and beyond will depend on a number variables over which the Company has no control.

Somero's operating model enables the Company to adjust quickly to changing conditions, protect profitability and preserve its strong financial position. In addition, it is important to highlight that the cost saving actions taken by management are specifically designed to not impact investment in new product development, a key element to the Company's long-term growth strategy. In fact, new product development activity remains at the high level seen in recent years.

The range and depth of impact from the COVID-19 pandemic creates significant short-term uncertainty, but the Board remains confident in the health of our business and the long-term growth opportunities in front of us. The Company is positioned well to withstand impacts from COVID-19, benefitting from a strong financial position, a flexible operating model, and a continued pipeline of new products to fuel growth, until such time as non-residential construction activity reverts to more normalized activity.

The Company will hold its Annual General Meeting on June 9, 2020 at 9 am local time via webcast. Registration information can be found at https://investors.somero.com/.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

Enquiries:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Carl Holmes (Corporate Finance)

Kate Bannatyne (Corporate Finance)

Tim Redfern (Corporate Broking)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

Rebecca Sanders-Hewett +44 (0) 2034 050 205

Susie Hudson

Sam Modlin

David Ison

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSDFDLESSESM
Date   Source Headline
8th Sep 20147:00 amRNSInterim Results
4th Sep 20145:27 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSTransaction in Own Shares
3rd Jul 20147:00 amRNSTrading Statement
16th Jun 20142:30 pmRNSTransaction in Own Shares
20th May 201412:04 pmRNSResult of AGM
19th May 20147:00 amRNSAGM Statement
1st May 20142:14 pmRNSAnnual Report and Notice of AGM
8th Apr 20147:00 amRNSFull year results for twelve months to 31/12/13
2nd Apr 20143:16 pmRNSHolding(s) in Company
11th Mar 20141:14 pmRNSHolding(s) in Company
5th Feb 20145:45 pmRNSDirector/PDMR Shareholding
30th Jan 20144:50 pmRNSDirector/PDMR Shareholding
14th Jan 20147:00 amRNSTrading Update
20th Dec 201312:36 pmRNSHolding(s) in Company
12th Dec 20132:45 pmRNSHolding(s) in Company
5th Dec 20134:07 pmRNSHolding(s) in Company
21st Nov 20132:31 pmRNSOption Buy-Back
15th Nov 20137:55 amRNSOption Buy-Back
30th Oct 20133:28 pmRNSDirector/PDMR Shareholding
28th Oct 20131:55 pmRNSHolding(s) in Company
18th Oct 20135:03 pmRNSHolding(s) in Company
17th Oct 20134:45 pmRNSHolding(s) in Company
8th Oct 20137:00 amRNSTrading Update
3rd Sep 20137:00 amRNSInterim Results
2nd Jul 20137:00 amRNSDirector/PDMR Shareholding
27th Jun 20137:42 amRNSDirector/PDMR Shareholding
26th Jun 20137:00 amRNSTransaction in Own Shares
19th Jun 20134:45 pmRNSDirector/PDMR Shareholding
13th Jun 20137:00 amRNSTrading Statement
20th May 20137:00 amRNSTransaction in Own Shares
30th Apr 20133:03 pmRNSResult of AGM
30th Apr 20137:00 amRNSAGM Statement
23rd Apr 201311:44 amRNSHolding(s) in Company
19th Apr 20134:46 pmRNSHolding(s) in Company
21st Mar 20137:00 amRNSDirector/PDMR Shareholding
20th Mar 20139:17 amRNSChange of Adviser
13th Mar 20137:00 amRNSAnnual Report and Notice of AGM
26th Feb 20137:00 amRNSFinal Results
3rd Jan 20134:06 pmRNSTrading Statement
7th Dec 201211:56 amRNSHolding(s) in Company
21st Nov 20125:21 pmRNSHolding(s) in Company
21st Aug 20127:00 amRNSHalf Yearly Report
24th Jul 20122:02 pmRNSHolding(s) in Company
24th Jul 20121:57 pmRNSHolding(s) in Company
24th Jul 20121:56 pmRNSHolding(s) in Company
20th Jul 201212:13 pmRNSHolding(s) in Company
17th Jul 20127:00 amRNSTrading Update
2nd Jul 20123:10 pmRNSHolding(s) in Company
22nd Jun 20124:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.